UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma

Oncotarget, 2017-02, Vol.8 (6), p.9388-9398

2017

Volltextzugriff (PDF)

Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia

Anti-cancer drugs, 2013-02, Vol.24 (2), p.189-197

2013

Volltextzugriff (PDF)

Associations of novel genetic variations in the folate‐related and ARID5B genes with the pharmacokinetics and toxicity of high‐dose methotrexate in paediatric acute lymphoblastic leukaemia

British journal of haematology, 2014-08, Vol.166 (3), p.410-420

2014

Volltextzugriff (PDF)

ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia

Cell biology international, 2012-01, Vol.36 (1), p.79-86

2012

Volltextzugriff (PDF)

Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia

Pathology oncology research, 2017-10, Vol.23 (4), p.889-897

2017

Volltextzugriff (PDF)

Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia

Pediatric blood & cancer, 2015-04, Vol.62 (4), p.622-628

2015

Volltextzugriff (PDF)

Urine catecholamines in paediatrics

Archives of Disease in Childhood. Education and Practice Edition, 2011-06, Vol.96 (3), p.107-111

2011

Volltextzugriff (PDF)

MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia

Journal of translational medicine, 2020-06, Vol.18 (1), p.250-250, Article 250

2020

Volltextzugriff (PDF)

Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia

Journal of translational medicine, 2019-11, Vol.17 (1), p.372-372, Article 372

2019

Volltextzugriff (PDF)

Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma

BMC cancer, 2018-07, Vol.18 (1), p.704-704, Article 704

2018

Volltextzugriff (PDF)

MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia

Molecular and cellular probes, 2023-02, Vol.67, p.101893-101893, Article 101893

2023

Volltextzugriff (PDF)

Two tagging single‐nucleotide polymorphisms to capture HLA‐DRB107:01–DQA102:01–DQB102:02 haplotype associated with asparaginase hypersensitivity

British journal of clinical pharmacology, 2021-06, Vol.87 (6), p.2542-2548

2021

Volltextzugriff (PDF)

Co-Detection of VEGF-A and Its Regulator, microRNA-181a, May Indicate Central Nervous System Involvement in Pediatric Leukemia

Pathology oncology research, 2022-04, Vol.28, p.1610096-1610096

2022

Volltextzugriff (PDF)

GSTM1 null and GSTT1 null: predictors of cisplatin-caused acute ototoxicity measured by DPOAEs

Journal of molecular medicine (Berlin, Germany), 2020-07, Vol.98 (7), p.963-971

2020

Volltextzugriff (PDF)

Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma

Journal of cancer research and clinical oncology, 2012-10, Vol.138 (10), p.1697-1702

2012

Volltextzugriff (PDF)

Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis

PloS one, 2013-08, Vol.8 (8), p.e69843-e69843

2013

Volltextzugriff (PDF)

Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance

BMC medical genomics, 2012-09, Vol.5 (1), p.42-42, Article 42

2012

Volltextzugriff (PDF)

Late Immune Recovery in Children Treated for Malignant Diseases

Pathology oncology research, 2008-12, Vol.14 (4), p.391-397

2008

Volltextzugriff (PDF)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia

Cancers, 2021-05, Vol.13 (10), p.2333

2021

Volltextzugriff (PDF)

Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity

PloS one, 2015-10, Vol.10 (10), p.e0140136-e0140136

2015

Volltextzugriff (PDF)

Pharmacogenetics of anthracyclines

Pharmacogenomics, 2016-06, Vol.17 (9), p.1075-1087

2016

Volltextzugriff (PDF)

Potential role of MAP2K1 mutation in the trans-differentiation of interdigitating dendritic cell sarcoma: Case report and literature review

Frontiers in pediatrics, 2022-09, Vol.10

2022

Volltextzugriff (PDF)

ALL-198: Pharmacogenetic Study on Central Nervous System Relapse Among Patients with Pediatric Acute Lymphoblastic Leukemia in Hungary

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S164-S164

2020

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(52)
Reviews
(6)
Texte
(2)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(35)
Humans
(29)
Child
(20)
Female
(16)
Pediatrics
(15)
Male
(14)
Child, Preschool
(13)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Genetics
(13)
Acute Lymphoblastic Leukemia
(12)
Adolescent
(12)
Leukemia
(12)
Oncology
(12)
Infant
(11)
Chemotherapy
(9)
Genotype
(8)
Patients
(8)
Polymorphism, Single Nucleotide
(8)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(8)
Acute Lymphocytic Leukemia
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Severe steroid‐related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma

Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia

Associations of novel genetic variations in the folate‐related and ARID5B genes with the pharmacokinetics and toxicity of high‐dose methotrexate in paediatric acute lymphoblastic leukaemia

ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia

Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia

Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia

Urine catecholamines in paediatrics

MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia

Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia

Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma

MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia

Two tagging single‐nucleotide polymorphisms to capture HLA‐DRB107:01–DQA102:01–DQB102:02 haplotype associated with asparaginase hypersensitivity

Co-Detection of VEGF-A and Its Regulator, microRNA-181a, May Indicate Central Nervous System Involvement in Pediatric Leukemia

GSTM1 null and GSTT1 null: predictors of cisplatin-caused acute ototoxicity measured by DPOAEs

Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma

Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis

Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance

Late Immune Recovery in Children Treated for Malignant Diseases

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia

Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk

Pharmacogenetics of anthracyclines

Potential role of MAP2K1 mutation in the trans-differentiation of interdigitating dendritic cell sarcoma: Case report and literature review

ALL-198: Pharmacogenetic Study on Central Nervous System Relapse Among Patients with Pediatric Acute Lymphoblastic Leukemia in Hungary

Suchergebnisse filtern